Morgan Stanley’s GH Research GHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.4M Buy
52,218
+26,388
+102% +$551K ﹤0.01% 5050
2026
Q1
$363K Sell
25,830
-25,574
-50% -$393K ﹤0.01% 5624
2025
Q4
$653K Buy
51,404
+47,162
+1,112% +$642K ﹤0.01% 5381
2025
Q3
$60.7K Sell
4,242
-276,760
-98% -$3.87M ﹤0.01% 6331
2025
Q2
$3.43M Buy
281,002
+3,751
+1% +$41.1K ﹤0.01% 4356
2025
Q1
$3.06M Buy
277,251
+11,783
+4% +$132K ﹤0.01% 4311
2024
Q4
$1.86M Buy
265,468
+6,848
+3% +$55.1K ﹤0.01% 4750
2024
Q3
$1.73M Sell
258,620
-33,325
-11% -$342K ﹤0.01% 4738
2024
Q2
$3.4M Buy
291,945
+10,631
+4% +$128K ﹤0.01% 4191
2024
Q1
$3M Sell
281,314
-40,916
-13% -$325K ﹤0.01% 4321
2023
Q4
$1.87M Buy
322,230
+15,021
+5% +$106K ﹤0.01% 4554
2023
Q3
$3.09M Sell
307,209
-86,529
-22% -$1,000K ﹤0.01% 4081
2023
Q2
$4.67M Buy
393,738
+1,883
+0.5% +$19.3K ﹤0.01% 3825
2023
Q1
$3.13M Sell
391,855
-132,260
-25% -$1.22M ﹤0.01% 4149
2022
Q4
$5.09M Buy
524,115
+34,779
+7% +$376K ﹤0.01% 3746
2022
Q3
$5.69M Buy
489,336
+10,717
+2% +$135K ﹤0.01% 3568
2022
Q2
$4.78M Buy
478,619
+57,171
+14% +$743K ﹤0.01% 3813
2022
Q1
$7.71M Sell
421,448
-23,013
-5% -$406K ﹤0.01% 3208
2021
Q4
$10.4M Buy
444,461
+20,201
+5% +$444K ﹤0.01% 2913
2021
Q3
$9.36M Buy
424,260
+222,532
+110% +$4.53M ﹤0.01% 2970
2021
Q2
$4.38M Buy
+201,728
New +$4.12M ﹤0.01% 3922

Other funds holding GHRS

Morgan Stanley's GHRS Position: Q2 2026 in Review

Morgan Stanley increased its GH Research (GHRS) stake by 102% in Q2 2026, buying an estimated $551K and bringing the position to 52,218 shares worth $1.4M. The position accounts for ﹤0.01% of the portfolio, ranked #5050.

Morgan Stanley first reported a position in GHRS in Q2 2021 and has held it in 21 quarters since. The position peaked at $10.4M in Q4 2021. 63 funds tracked by Wall St. Rank hold GHRS as of Q2 2026.

  • Morgan Stanley held 52,218 shares of GH Research worth $1.4M as of Q2 2026.
  • Morgan Stanley bought 26,388 GH Research shares in Q2 2026, an estimated $551K.
  • GH Research made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #5050 holding.
  • Morgan Stanley first reported a position in GH Research in Q2 2021 and has held it in 21 quarters since.
  • Morgan Stanley's GH Research position peaked at $10.4M in Q4 2021.
  • 63 funds tracked by Wall St. Rank held GH Research as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.